Diet Intervention and GEnetic STudy (DIGEST-Pilot)

Cardiovascular Diseases Clinical Trial

— DIGEST  

Official title:

Dietary Intervention Trial to Understand the Mechanism Underlying the 9p21 Variant Interaction With High Fruits and Vegetable Consumption

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT01658137
• Other study ID #: DIGEST-Pilot
• Status: Active, not recruiting
• Phase: N/A
• First received: July 28, 2012
• Last updated: June 5, 2016
• Start date: July 2012
• Est. completion date: December 2016

Study information

• Verified date: June 2016
• Source: McMaster University
• Contact: n/a
• Is FDA regulated: No
• Health authority: Canada: Ethics Review Committee
• Study type: Interventional

Clinical Trial Summary

Genetic factors contribute to risk factors for cardiovascular disease, such as blood lipids, blood pressure, obesity, diabetes, and may also influence dietary choices, physical activity, and responses to stress. The most robust genetic variant associated with myocardial infarction (MI) is the 9p21 variant, which may raise the risk of MI by up to 40% in those who carry 2 copies of the gene. The investigators recently found that among those who carry the 9p21 variant, the risk of MI may be "turned off" if individuals eat a diet high in fruits and vegetables. The investigators seek to determine how a "prudent" or "anti-inflammatory" diet interacts with the 9p21 risk allele to alter the risk of MI.

Description:

Cardiovascular disease (CVD) is the leading cause of death globally. The majority of CVD is explained by conventional risk factors including cigarette smoking, abnormal lipids, high blood pressure, obesity, diabetes, and health behaviours including dietary intake, physical activity, and psychosocial stressors. Genetic factors contribute to the development of these risk factors, and directly to CVD through other novel pathways. Since the advent of high throughput chip-based genotyping, more than 30 genetic variants have been found to be associated with myocardial infarction. The most robust genetic variant which has been consistently associated with myocardial infarction and other forms of arterial disease is the 9p21 variant. This genetic variant located on Chromosome 9 is common in the population, with 50% of people carrying one copy of the risk allele, and an additional 25% of the population carrying two copies of the risk allele. Compared with those with no copies of the risk allele, the risk of myocardial infarction with one copy of the risk allele is 15-20% higher, and the increased risk among carriers of 2 risk alleles is 20-40%. To date the exact mechanism by which the 9p21 variant increases the risk of myocardial infarction is unknown, although some data suggests that other genes and pathways associated with cell proliferation and inflammation are involved. Recently we made the observation that among carriers of the 9p21 variant, the risk of MI may be "turned off" if individuals consumed a diet high in fruits and vegetables. However the "mechanism" underlying this interaction is unknown. We seek to discover how a "Prudent" (i.e. anti-inflammatory) diet interacts with the 9p21 risk allele(s) to alter the risk of myocardial infarction.

We postulate that a "Prudent" diet (i.e. a diet high in fruits, vegetables, whole grains, non-processed foods) in comparison to a "Western" or "inflammatory diet" (eg, a typical North American diet high in saturated fats and processed foods) will differentially alter the gene expression (measured by RNA) of the 9p21 locus, change the epigenetic marks in this region, and alter several inflammatory markers suspected to mediate the effect of 9p21 on CVD risk (eg, hs-CRP, IF-alpha21, IFN-γ , interleukin 1-alpha, interleukin 1-beta, and interleukin 6) among people with one or two copies of the risk allele compared to people without the risk allele.

The proposed study offers an unique approach to studying dietary relationships with endpoints believed to be influenced by 9p21 gene variants. Rather than testing nutritional supplements, our results will be generalizable to the setting of most dietary counseling practices, which aim to alter dietary patterns, not specific nutrients. This trial will help us to unravel the basis for gene-diet interactions and gain a greater understanding of how inflammation is linked to the development of atherosclerosis, CVD, and possibly some cancers.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 84
• Est. completion date: December 2016
• Est. primary completion date: December 2016
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

• 18-80 years old

• non-smokers

• Body-Mass-Index <=30 kg/m^2

• willing and able to cook, prepare, and eat provided study foods

Exclusion Criteria:

• Aged below 18 years or above 80 years

• current tobacco smoking

• Body mass index above 30 kg/m2

• Unwillingness or inability to cook, prepare and eat provided study foods (e.g. for medical, philosophical, or religious reasons)

• Excessive use of alcohol (>14 drinks/week in men; >7 drinks/week in women)

• Significant morbidity that would interfere with participation or assessment, including :

• Cancer

• HIV

• chronic renal disease

• renal failure

• Hepatitis/Jaundice

• Liver Disease

• Chronic Obstructive Pulmonary Disease

• Inflammatory bowel disease (Crohn's / Colitis)

• High blood or urine sugar/diabetes

• High blood cholesterol or triglycerides

• Angina/Heart attack/Coronary artery disease

• Heart failure

• Other heart disease

• Angioplasty (balloon opening of an artery) or coronary bypass surgery

• Medications or nutritional supplements (including multivitamins) that could affect outcome measurements. Excluded medications would include:

• Lipid/cholesterol lowering pills

• Insulin/oral hypoglycemic agents

• Medication for stroke

• Antibiotics

• oral contraceptives

• hormone replacement therapy

• non-steroidal anti-inflammatory drugs

• corticosteroids

• unwillingness to stop nutritional supplements 1 week prior to and for duration of intervention

• anticipated difficulties maintaining body weight (e.g. athletic training)

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention

Related Conditions & MeSH terms

• Blood Pressure
• Cardiovascular Diseases
• Dyslipidemias
• Hyperglycemia
• Inflammation

Intervention

Other:
• Prudent Diet
This intervention lasts 2 weeks (14 days).
• Typical Western Diet
This intervention lasts 2 weeks (14 days).

Locations

Country	Name	City	State
Canada	McMaster University	Hamilton	Ontario

Sponsors (1)

Lead Sponsor	Collaborator
McMaster University

Country where clinical trial is conducted

Canada, 

References & Publications (6)

Anand SS, Yusuf S. Stemming the global tsunami of cardiovascular disease. Lancet. 2011 Feb 12;377(9765):529-32. doi: 10.1016/S0140-6736(10)62346-X. Epub 2011 Feb 4. — View Citation

Do R, Xie C, Zhang X, Männistö S, Harald K, Islam S, Bailey SD, Rangarajan S, McQueen MJ, Diaz R, Lisheng L, Wang X, Silander K, Peltonen L, Yusuf S, Salomaa V, Engert JC, Anand SS; INTERHEART investigators. The effect of chromosome 9p21 variants on cardiovascular disease may be modified by dietary intake: evidence from a case/control and a prospective study. PLoS Med. 2011 Oct;8(10):e1001106. doi: 10.1371/journal.pmed.1001106. Epub 2011 Oct 11. — View Citation

Hu FB, Rimm EB, Stampfer MJ, Ascherio A, Spiegelman D, Willett WC. Prospective study of major dietary patterns and risk of coronary heart disease in men. Am J Clin Nutr. 2000 Oct;72(4):912-21. — View Citation

McPherson R, Pertsemlidis A, Kavaslar N, Stewart A, Roberts R, Cox DR, Hinds DA, Pennacchio LA, Tybjaerg-Hansen A, Folsom AR, Boerwinkle E, Hobbs HH, Cohen JC. A common allele on chromosome 9 associated with coronary heart disease. Science. 2007 Jun 8;316(5830):1488-91. Epub 2007 May 3. — View Citation

Mente A, de Koning L, Shannon HS, Anand SS. A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med. 2009 Apr 13;169(7):659-69. doi: 10.1001/archinternmed.2009.38. Review. — View Citation

O'Donnell CJ, Nabel EG. Genomics of cardiovascular disease. N Engl J Med. 2011 Dec 1;365(22):2098-109. doi: 10.1056/NEJMra1105239. Review. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	gene expression measuring ANRIL production		baseline and 2 weeks	No
Primary	epigenetic marks		baseline and 2 weeks	No
Secondary	high-sensitivity C-reactive protein	Biomarker of inflammation	baseline and 2 weeks	No
Secondary	interferon-alpha-21	Biomarker of inflammation	baseline and 2 weeks	No
Secondary	interferon-gamma	Biomarker of inflammation	baseline and 2 weeks	No
Secondary	interleukin-1-alpha	Biomarker of inflammation	baseline and 2 weeks	No
Secondary	total cholesterol	lipid risk factor for cardiovascular disease	baseline and 2 weeks	No
Secondary	low-density lipoprotein-cholesterol	lipid risk factor for cardiovascular disease	baseline and 2 weeks	No
Secondary	high-density lipoprotein-cholesterol	lipid risk factor for cardiovascular disease	baseline and 2 weeks	No
Secondary	apolipoprotein-B	lipid risk factor for cardiovascular disease	baseline and 2 weeks	No
Secondary	fasting glucose	indicator of insulin resistance	baseline and 2 weeks	No
Secondary	systolic blood pressure	mmHg	baseline and 2 weeks	No
Secondary	diastolic blood pressure	mmHg	baseline and 2 weeks	No
Secondary	interleukin-6	Biomarker of inflammation	baseline and 2 weeks	No

External Links

•   Study information website (in progress)